SEC Form 4 · accession 0001591868-16-000004
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jessica Baker Flechtner
Officer — Chief Scientific Officer
Period of report
Dec 13, 2016
Accepted (ET)
Dec 15, 2016 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common StockF1 | $3.45 | Dec 13, 2016 | M | 6,000 | A | — | Jul 24, 2023 | Common Stock | 6,000 | 50,378 | D |
Explanation of responses
- F1The option was granted on 7/25/2013 and vests in equal monthly installments for the next 48 months thereafter.